# Purdue Pharmaceuticals LP, Wilson, NC – FDA Inspections

Source: https://www.keypedia.com/companies/purdue-pharmaceuticals-lp/404112a8-6b5a-4bea-9890-9c5f6339ca44

> Inspection records and compliance data for Purdue Pharmaceuticals LP in Wilson, North Carolina. 6 FDA inspections on record, last inspected August 11, 2022.

---

## Details

- Name: Purdue Pharmaceuticals LP
- FEI Number: 3002960808
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 4701 International Blvd
- City: Wilson
- State: North Carolina
- Zip Code: 27893
- Country Name: United States
- Address: 4701 International Blvd, Wilson, North Carolina 27893, United States
- Country: United States

## Related Documents

- 483 - Purdue Pharmaceuticals LP - 2022-08-11 — source: FDA, date: August 11, 2022
- [FDA Inspection 1178224 - Purdue Pharmaceuticals LP - 2022-08-11](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/1d7d0437-a69f-4578-a184-eed521ea55d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2022
- [483 - Purdue Pharmaceuticals LP - 2019-12-19](https://www.keypedia.com/records/483/purdue-pharmaceuticals-lp/40ab1419-91d2-40cf-ac2f-92c939187f63) — source: FDA, date: December 19, 2019
- [FDA Inspection 1113735 - Purdue Pharmaceuticals LP - 2019-12-19](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/4b966855-9072-4061-a107-40808e0ea1da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2019
- [EIR - Purdue Pharmaceuticals LP - 2017-08-24](https://www.keypedia.com/records/eir/purdue-pharmaceuticals-lp/2e360352-1a6a-49a3-adad-141612387f11) — source: FDA, date: August 24, 2017
- FDA Inspection 1028417 - Purdue Pharmaceuticals LP - 2017-08-24 — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2017
- FDA Inspection 888629 - Purdue Pharmaceuticals LP - 2014-07-17 — classification: No Action Indicated (NAI), source: FDA, date: July 17, 2014
- FDA Inspection 860931 - Purdue Pharmaceuticals LP - 2013-11-08 — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013
- FDA Inspection 708668 - Purdue Pharmaceuticals LP - 2011-01-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 27, 2011

## Related Companies

- [SOFIE Co](https://www.keypedia.com/companies/sofie-co/d06f8036-2bc5-4dbb-885b-341a1ecbb82a)
- [KDC/ONE SOCAL LABORATORIES, LLC](https://www.keypedia.com/companies/kdcone-socal-laboratories-llc/d02dae40-fdd7-4623-934b-cb99482e07c9)
- [CELESTE INDUSTRIES CORPORATION](https://www.keypedia.com/companies/celeste-industries-corporation/236f5bc7-a113-4e4e-95eb-5131b3cc602b)
- [Cosmetic Group USA, Inc.](https://www.keypedia.com/companies/cosmetic-group-usa-inc/6ad3be3e-b2d8-4b6b-8d7a-56cc69f8283c)
- [Airgas USA, LLC](https://www.keypedia.com/companies/airgas-usa-llc/77906ce6-4c76-4e6f-a6f9-d94dc56e6a7e)
- [Avadel CNS Pharmaceuticals LLC](https://www.keypedia.com/companies/avadel-cns-pharmaceuticals-llc/6ed86f03-0d25-4dd6-91c0-b0c3725ceaa8)
- [Lonza Tampa LLC](https://www.keypedia.com/companies/lonza-tampa-llc/6ba00e57-ba56-45fd-9718-cb91a9b2458a)
- [REGI US INC](https://www.keypedia.com/companies/regi-us-inc/0596d9b3-58c6-48ab-89fb-096ab585b2dd)
- [Linde, Inc. dba Praxair, Inc](https://www.keypedia.com/companies/linde-inc-dba-praxair-inc/e373ec1f-fe25-449c-b9eb-8ccf361ea32e)
- [Linde Gas & Equipment Inc](https://www.keypedia.com/companies/linde-gas-equipment-inc/073afdf5-10c2-49df-975e-272779a05594)

## Related Officers

- [Owner/Inspector](https://www.keypedia.com/people/jared-p-stevens/11cd48ff-e61f-4448-98be-efe2f8377fc1)
- [Investigator](https://www.keypedia.com/people/sonya-m-edmonds/a38fad3f-f664-4c52-8e50-78782f56ff18)
- [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
